fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Mirtazapine is ineffective, possibly dangerous, for agitation in dementia

Written by | 28 Oct 2021

Mirtazapine, an antidepressant often used to treat agitation in patients with dementia, is ineffective, researchers reported on Oct. 21, 2021 in The Lancet. And the investigators found a… read more.

Researchers find warning signs for dementia in the blood

Written by | 24 Oct 2021

Certain microRNAs indicate risk for cognitive decline DZNE – German Center for Neurodegenerative Diseases Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules… read more.

Menopausal hormone therapy not linked to dementia onset

Written by | 22 Oct 2021

Menopausal hormone therapy (MHT — also known as hormone replacement therapy, HRT) does not appear to increase the risk of dementia onset, researchers reported on Sept. 29, 2021… read more.

A new framework for protecting mental health in cities

Written by | 12 Oct 2021

People who live in cities face many challenges that threaten their mental health. In countries in which relatively higher numbers of people live in cities, depression, anxiety and… read more.

What our wandering thoughts can teach us about mental health

Written by | 7 Oct 2021

Where does your mind wander when you have idle time? A University of Arizona-led study published in Scientific Reports may offer some clues, and the findings reveal a… read more.

More effective treatment of Alzheimer’s

Written by | 4 Oct 2021

Researchers at Uppsala University have designed new antibodies that might provide more effective treatment methods for Alzheimer’s disease. By designing antibodies that bind even to the smaller aggregates,… read more.

Research reveals drug targets for memory enhancement

Written by | 30 Sep 2021

Loss of memory is a core feature of many neurological and psychiatric disorders including Alzheimer’s disease and schizophrenia. Current treatment options for memory loss are very limited and… read more.

Screen time only mildly linked to behavioral problems, but may have social benefits

Written by | 26 Sep 2021

Study of nearly 12,000 kids finds no link to depression, anxiety University of Colorado at Boulder School-aged children who spend more time in front of screens are only… read more.

FDA approves Invega Hayfera (6-month paliperidone palmitate), first and only twice-yearly treatment for adults with schizophrenia – Janssen Pharmaceuticals

Written by | 24 Sep 2021

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the FDA has approved long-acting atypical antipsychotic Invega Hafyera (6-month paliperidone palmitate), the first-and-only twice-yearly injectable for the… read more.

Eye conditions linked to heightened risk of dementia

Written by | 20 Sep 2021

Risk of dementia increases with age-related macular degeneration, cataract and diabetes-related eye disease, but not glaucoma. Age-related macular degeneration, cataract and diabetes-related eye disease are linked to an… read more.

Predicting possible Alzheimer’s with nearly 100 percent accuracy

Written by | 8 Sep 2021

Researchers from Kaunas universities, Lithuania developed a deep learning-based method that can predict the possible onset of Alzheimer’s disease from brain images with an accuracy of over 99… read more.

Physical health predicts mental well-being during pandemic

Written by | 4 Sep 2021

Pre-pandemic physiological data can help predict how individuals coped with the psychological strain many suffered during the COVID-19 pandemic, according to a new study published in the journal Psychophysiology…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.